Host genetic factors can impact vaccine immunogenicity and effectiveness.

[1]  J. Chies,et al.  CCR5 gene editing - Revisiting pros and cons of CCR5 absence. , 2019, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.

[2]  Virgie S. Fields,et al.  Mumps in a highly vaccinated Marshallese community in Arkansas, USA: an outbreak report. , 2019, The Lancet. Infectious diseases.

[3]  A. Bowen,et al.  Mumps outbreaks in ethnic subpopulations: what can we learn? , 2019, The Lancet. Infectious diseases.

[4]  V. Lange,et al.  Frequencies of gene variant CCR5-Δ32 in 87 countries based on next-generation sequencing of 1.3 million individuals sampled from 3 national DKMS donor centers. , 2017, Human immunology.

[5]  K. Skonieczna-Żydecka,et al.  Possible Impact of 190G > A CCR2 and Δ32 CCR5 Mutations on Decrease of the HBV Vaccine Immunogenicity—A Preliminary Report , 2017, International journal of environmental research and public health.